Meitav Dash Investments »

Halozyme Therapeutics shares owned by Meitav Dash Investments

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Meitav Dash Investments from 13F filings

Historical chart of Meitav Dash Investments investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Meitav Dash Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Meitav Dash Investments

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.0M 63k 63.74

More positions owned by Meitav Dash Investments

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Financial (XLF)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Amazon (AMZN)
Ishares Tr Msci China Etf (MCHI)
Vaneck Etf Trust Semiconductr Etf (SMH)
Wisdomtree Tr India Erngs Fd (EPI)
NOVA MEASURING Instruments L (NVMI)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Select Sector Spdr Tr Sbi Int-utils (XLU)
Select Sector Spdr Tr Indl (XLI)
Tower Semiconductor Shs New (TSEM)

View all positions for Meitav Dash Investments

Top funds holding Halozyme Therapeutics

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Snyder Capital Management
Alliancebernstein
Artisan Partners Limited Partnership
Macquarie Group
Geode Capital Management
Jpmorgan Chase & Co
Congress Asset Management
Bank of America Corporation
Arrowpoint Asset Management
Handelsbanken Fonder AB
Invesco

View all funds holding Halozyme Therapeutics